drugset / Trial / NCT04084548

Perioperative Lidocaine and Ketamine in Abdominal Surgery

NCT04084548

Phase 3 Active not recruiting 420 enrolled The Cleveland Clinic
RandomizedFactorialQuadruple-blindTreatment

Summary

The investigators propose to test the hypothesis that perioperative infusions of lidocaine and/or ketamine reduce opioid consumption and pain scores in adults recovering from elective inpatient abdominal surgery.

Timeline

Start
2019-10-15
Primary completion
2025-12
Completion
2025-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.3 mg/kg Other
Subject Lidocaine Other / unclassified 2 mg/kg Other

Indications

No indication recorded.